Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

NCT ID: NCT03579641

Last Updated: 2022-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2184 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-01

Study Completion Date

2021-10-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the PREEMPT-HF study is to collect device and clinical event data to evaluate extended applications of the HeartLogic Heart Failure Diagnostic (HeartLogic) in a broad spectrum of heart failure patients with an implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator. There are no primary safety and/or efficacy endpoints for this study.

Heart failure is a complex clinical syndrome with high morbidity, mortality, and economic burden. Chronic Heart Failure is persistent, gradually progressive, and punctuated by episodes of acute worsening leading to hospitalizations. Therefore, there remains an unmet clinical need to slow the progression of Heart Failure and prevent hospitalizations. HeartLogic, available in Boston Scientific cardiac resynchronization therapy devices and defibrillators, combines novel sensor parameters such as heart sounds and respiration with other measurements like thoracic impedance, heart rate, and activity into a HeartLogic Index for the early detection of worsening Heart Failure. However, there is limited data on the association of HeartLogic with the risk of Hear Failure readmissions and tachyarrhythmias, or for phenotyping the broad spectrum of Heart Failure patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will be followed for approximately 12 months after the baseline visit to collect the required number of clinical events to support the study objectives. These events are called Reviewable Clinical Events, and include all-cause hospitalizations and Heart Failure outpatient visits.

Clinical event definitions are as follows:

* Hospitalization (all-cause): the subject is admitted to inpatient hospital care and discharged on a different calendar date.
* Heart Failure Hospitalization: the subject is admitted with signs/symptoms of congestive heart failure and receives unscheduled augmented Heart Failure therapy with oral or intravenous medications, ultrafiltration therapy or other parenteral therapy.
* Heart Failure Readmission (30-day): the subject is admitted for an unplanned hospitalization for any cause within 30 days post discharge from a Heart Failure hospitalization.
* Heart Failure Outpatient Visit: the subject has signs/symptoms of Congestive Heart Failure, and receives unscheduled intravenous decongestive therapy (e.g., Intravenous diuretics, Intravenous inotropes, Intravenous vasoactive drugs, ultrafiltration) in a setting that does not involve a hospitalization (e.g., emergency room, Heart Failure clinic, primary care clinic, etc.).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Defibrillators, Implantable Monitoring, Physiologic Cardiac Resynchronization Therapy Cardiovascular Disease Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Implantable Cardiac device with HeartLogic feature

Patients with Heart Failure, implanted with Boston Scientific Implantable Cardioverter Defibrillator or Defibrillator with Cardiac Resynchronization device with HeartLogic feature

HeartLogic Sensors

Intervention Type DEVICE

HeartLogic Sensors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HeartLogic Sensors

HeartLogic Sensors

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is age 18 or above, or of legal age to give informed consent specific to each country and national laws.
* Subject has a documented diagnosis of heart failure.
* Subject has a Boston Scientific Cardiac Resynchronization Therapy Defibrillator or Implantable Cardioverter Defibrillator device implant that has HeartLogic, with Heart Failure Sensors turned ON, Respiratory Sensor turned ON, and Sleep Incline Sensor turned ON.
* Subject has an active bipolar right ventricle lead implant.
* Subject is enrolled in LATITUDE (NXT 5.0 or future version), and is willing to be remotely monitored from the baseline visit for approximately 12 months with HeartLogic disabled.

Exclusion Criteria

* Subject has received or is scheduled to receive a heart transplant or ventricular assist device (VAD).
* Subject is enrolled in any concurrent clinical study without prior Boston Scientific written approval (excluding registries).
* Subject has a life expectancy of less than 12 months.
* Subject has a history of non-compliance to medical care or known inability to comply with requirements of the clinical study protocol
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen Gaertner

Role: STUDY_DIRECTOR

Boston Scientific Corporation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baptist Medical Center Princeton

Birmingham, Alabama, United States

Site Status

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Cardiology Associates of Northeast Arkansas

Jonesboro, Arkansas, United States

Site Status

Baptist Health Medical Center (Little Rock)

Little Rock, Arkansas, United States

Site Status

Providence St. Joseph Medical Center

Burbank, California, United States

Site Status

Mission Hospital

Mission Viejo, California, United States

Site Status

Stanford University Medical Center

Stanford, California, United States

Site Status

Harbor UCLA Medical Center

Torrance, California, United States

Site Status

Torrance Memorial Medical Center

Torrance, California, United States

Site Status

Cardiology Physicians, PA

Newark, Delaware, United States

Site Status

Baptist Medical Center

Jacksonville, Florida, United States

Site Status

Watson Clinic Center for Research, Inc.

Lakeland, Florida, United States

Site Status

Sarasota Memorial Hospital

Sarasota, Florida, United States

Site Status

Tallahassee Memorial Hospital

Tallahassee, Florida, United States

Site Status

Florida Hospital

Winter Park, Florida, United States

Site Status

CorVita Science Foundation (NFP)

Chicago, Illinois, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Evanston Hospital

Evanston, Illinois, United States

Site Status

St. John's Hospital

Springfield, Illinois, United States

Site Status

Carle Foundation Hospital

Urbana, Illinois, United States

Site Status

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status

University of Kansas Hospital

Kansas City, Kansas, United States

Site Status

Eastern Maine Medical Center

Bangor, Maine, United States

Site Status

University of Maryland Medical System

Baltimore, Maryland, United States

Site Status

Boston Medical Center

Boston, Massachusetts, United States

Site Status

Mass Heart and Rhythm

Leominster, Massachusetts, United States

Site Status

Advanced Cardiovascular Clinic

Flint, Michigan, United States

Site Status

Bronson Methodist Hospital

Kalamazoo, Michigan, United States

Site Status

William Beaumont Hospital

Royal Oak, Michigan, United States

Site Status

St. Luke's Hospital-Duluth

Duluth, Minnesota, United States

Site Status

Regions Hospital

Saint Paul, Minnesota, United States

Site Status

Hattiesburg Clinic, P.A.

Hattiesburg, Mississippi, United States

Site Status

Heart and Vascular Hattiesburg Clinic

Hattiesburg, Mississippi, United States

Site Status

St. Joseph Mercy Hospital Oakland

Pontiac, Missouri, United States

Site Status

Barnes Jewish Hospital

St Louis, Missouri, United States

Site Status

Albany Medical Center

Albany, New York, United States

Site Status

Capital Cardiology Associates

Albany, New York, United States

Site Status

Columbia University Medical Center

New York, New York, United States

Site Status

Strong Memorial Hospital of the University of Rochester

Rochester, New York, United States

Site Status

University of North Carolina Hospital

Chapel Hill, North Carolina, United States

Site Status

Aultman Hospital

Canton, Ohio, United States

Site Status

Southern Oregon Cardiology, LLC

Medford, Oregon, United States

Site Status

Providence St. Vincent Medical Center

Portland, Oregon, United States

Site Status

Abington Memorial Hospital

Abington, Pennsylvania, United States

Site Status

Lehigh Valley Hospital

Allentown, Pennsylvania, United States

Site Status

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

St. Francis Health System - St. Francis Hospital

Greenville, South Carolina, United States

Site Status

Erlanger Medical Center

Chattanooga, Tennessee, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Seton Medical Center

Austin, Texas, United States

Site Status

The University of Texas, Southwestern Medical Center

Dallas, Texas, United States

Site Status

Orion Medical

Pasadena, Texas, United States

Site Status

Christus Trinity Mother Frances Health System

Tyler, Texas, United States

Site Status

Riverside Regional Medical Center

Newport News, Virginia, United States

Site Status

Providence Regional Medical Center Everett

Everett, Washington, United States

Site Status

St. Mary's Medical Center

Huntington, West Virginia, United States

Site Status

Prince Charles Hospital

Chermside, , Australia

Site Status

OLVZ Aalst

Aalst, , Belgium

Site Status

CHUM

Montreal, , Canada

Site Status

IUCPQ

Ste-Foy, , Canada

Site Status

Aarhus University Hospital

Aarhus, , Denmark

Site Status

CHU de Caen

Caen, , France

Site Status

CHU de Nantes - Hôpital Laennec

Nantes, , France

Site Status

APHP - Hospital de la Pitie-Salpetriere

Paris, , France

Site Status

CHU de St. Etienne

Saint-Priest-en-Jarez, , France

Site Status

Augusta Kranken Anstalt GmbH - Klinik für Kardiologie und Angiologie

Bochum, , Germany

Site Status

Universitaetsklinikum Schleswig-Holstein

Lübeck, , Germany

Site Status

Grantham Hospital

Aberdeen, , Hong Kong

Site Status

Prince of Wales Hospital

Hong Kong, , Hong Kong

Site Status

Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

University Hospital Waterford

Waterford, , Ireland

Site Status

Az. Osp. G. Ciaccio Pontepiccolo

Catanzaro, , Italy

Site Status

Az. Osp. Monaldi

Naples, , Italy

Site Status

Ospedale Sacro Cuore Don Calabria

Negrar, , Italy

Site Status

Azienda Osp Univ Integrata di Verona

Verona, , Italy

Site Status

AMC

Amsterdam, , Netherlands

Site Status

Leiden University Medical Center

Leiden, , Netherlands

Site Status

Universitair Medisch Centrum

Utrecht, , Netherlands

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital de Gran Canaria Dr. Negrin

Las Palmas, , Spain

Site Status

Hospital Universitario Virgen De La Victoria

Málaga, , Spain

Site Status

Belfast City Hospital

Belfast, , United Kingdom

Site Status

Golden Jubilee National Hospital

Clydebank, , United Kingdom

Site Status

Ninewells Hospital and Medical School

Dundee, , United Kingdom

Site Status

Royal Infirmary of Edinburgh

Edinburgh, , United Kingdom

Site Status

South Manchester University Hospital Trust

Manchester, , United Kingdom

Site Status

Northern General Hospital

Sheffield, , United Kingdom

Site Status

New Cross Hospital

Wolverhampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium Canada Denmark France Germany Hong Kong Ireland Italy Netherlands Spain United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. No abstract available.

Reference Type BACKGROUND
PMID: 28122885 (View on PubMed)

Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133. doi: 10.1016/j.jacc.2013.11.053. Epub 2014 Feb 5.

Reference Type BACKGROUND
PMID: 24491689 (View on PubMed)

Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009 Feb 17;53(7):557-573. doi: 10.1016/j.jacc.2008.10.041.

Reference Type BACKGROUND
PMID: 19215829 (View on PubMed)

Boehmer JP, Hariharan R, Devecchi FG, Smith AL, Molon G, Capucci A, An Q, Averina V, Stolen CM, Thakur PH, Thompson JA, Wariar R, Zhang Y, Singh JP. A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study. JACC Heart Fail. 2017 Mar;5(3):216-225. doi: 10.1016/j.jchf.2016.12.011.

Reference Type BACKGROUND
PMID: 28254128 (View on PubMed)

Whellan DJ, Lindenfeld J. Easy to Predict, Difficult to Prevent. JACC Heart Fail. 2017 Mar;5(3):226-228. doi: 10.1016/j.jchf.2017.01.006. No abstract available.

Reference Type BACKGROUND
PMID: 28254129 (View on PubMed)

Desai AS. The three-phase terrain of heart failure readmissions. Circ Heart Fail. 2012 Jul 1;5(4):398-400. doi: 10.1161/CIRCHEARTFAILURE.112.968735. No abstract available.

Reference Type BACKGROUND
PMID: 22811548 (View on PubMed)

Dharmarajan K, Wang Y, Lin Z, Normand ST, Ross JS, Horwitz LI, Desai NR, Suter LG, Drye EE, Bernheim SM, Krumholz HM. Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge. JAMA. 2017 Jul 18;318(3):270-278. doi: 10.1001/jama.2017.8444.

Reference Type BACKGROUND
PMID: 28719692 (View on PubMed)

Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, Bonow RO, Huang CC, Deo RC. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015 Jan 20;131(3):269-79. doi: 10.1161/CIRCULATIONAHA.114.010637. Epub 2014 Nov 14.

Reference Type BACKGROUND
PMID: 25398313 (View on PubMed)

Sauer AJ, Stolen CM, Shute JB, Kwan B, Wariar R, Ruble SB, Gardner RS, Boehmer JP. Results of the Precision Event Monitoring for Patients With Heart Failure Using HeartLogic Study (PREEMPT-HF). JACC Heart Fail. 2025 Jun;13(6):973-983. doi: 10.1016/j.jchf.2025.01.028. Epub 2025 Apr 23.

Reference Type DERIVED
PMID: 40272337 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PREEMPT-HF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.